In a the joint opinion piece in Altinget Sverige, CEO of Lif Sweden Sofia Wallström and MVA CEO Anette Steenberg argue that pharmaceutical innovation must be treated as what it truly is: a strategic investment in Europe’s future. Obviously, the two leading life science nations of the Nordics can and must contribute.
You can read the piece “It is dangerous for Europe if our life science industry is lagging behind“, but it is in Swedish, as it happens to be the language most common used in Sweden.
Highlights from The MVA General Assembly 2026
Medicon Valley Alliance held its Annual General Assembly on April 9, opened by MVA Chair Niels Abel Bonde. CEO Anette Steenberg followed with a...